Philogen announces publication of best-in-class FAP-targeting small molecule ligand (OncoFAP) in PNAS
Study shows impressive tumor uptake of OncoFAP with unprecedented selectivity against healthy organs. OncoFAP-based molecules are currently being developed for the imaging and therapy of cancer. Philogen announces participation to...Read more
Philogen announces its participation at the CEO Roundtable Zoom Session organised by Goldman Sachs from June 8 to 29, 2021. Co-founder, CEO and CSO, Prof. Dario Neri has been invited to share and discuss all...Read more
Philogen participates at the BIO Digital 2021, the international partnering event in the life science and pharma industry, on June 14-18, 2021. Please meet with us in case you are interested...Read more
Philogen announces the organization of a non-deal Roadshow with Investors on July 5-7, 2021. The event will be organised together with Mediobanca, Goldman Sachs and Stifel.